Joseph Maddry
Concepts (350)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Military Personnel | 42 | 2024 | 726 | 6.370 |
Why?
| | Emergency Medical Services | 32 | 2025 | 680 | 4.710 |
Why?
| | Air Ambulances | 17 | 2025 | 56 | 4.700 |
Why?
| | Wounds and Injuries | 24 | 2026 | 959 | 3.570 |
Why?
| | Afghan Campaign 2001- | 27 | 2024 | 182 | 3.330 |
Why?
| | Resuscitation | 14 | 2025 | 314 | 3.260 |
Why?
| | Military Medicine | 13 | 2025 | 148 | 2.490 |
Why?
| | Emergency Medicine | 8 | 2025 | 280 | 2.330 |
Why?
| | Critical Care | 16 | 2024 | 706 | 2.270 |
Why?
| | Patient Transfer | 6 | 2025 | 224 | 2.250 |
Why?
| | Iraq War, 2003-2011 | 19 | 2024 | 163 | 2.060 |
Why?
| | Patient Handoff | 3 | 2025 | 45 | 2.040 |
Why?
| | Hydroxocobalamin | 4 | 2023 | 33 | 1.610 |
Why?
| | Transportation of Patients | 5 | 2024 | 62 | 1.510 |
Why?
| | Compartment Syndromes | 2 | 2024 | 36 | 1.470 |
Why?
| | Trauma Centers | 4 | 2025 | 441 | 1.260 |
Why?
| | Ketamine | 8 | 2023 | 144 | 1.210 |
Why?
| | Antidotes | 6 | 2021 | 145 | 1.200 |
Why?
| | War-Related Injuries | 9 | 2019 | 46 | 1.190 |
Why?
| | Warfare | 7 | 2020 | 99 | 1.160 |
Why?
| | Respiration, Artificial | 4 | 2024 | 711 | 1.110 |
Why?
| | Shock, Hemorrhagic | 5 | 2025 | 195 | 1.100 |
Why?
| | Hemorrhage | 9 | 2025 | 825 | 1.090 |
Why?
| | Brain Injuries, Traumatic | 4 | 2025 | 466 | 1.050 |
Why?
| | Tourniquets | 2 | 2018 | 34 | 1.040 |
Why?
| | Thoracotomy | 2 | 2025 | 87 | 1.030 |
Why?
| | Hemodynamics | 9 | 2025 | 1114 | 1.000 |
Why?
| | Airway Management | 8 | 2021 | 84 | 0.980 |
Why?
| | Swine | 17 | 2026 | 821 | 0.960 |
Why?
| | Intubation, Intratracheal | 11 | 2025 | 330 | 0.940 |
Why?
| | Remote Consultation | 3 | 2018 | 67 | 0.920 |
Why?
| | Laryngoscopes | 5 | 2025 | 45 | 0.910 |
Why?
| | Toxicology | 2 | 2016 | 49 | 0.880 |
Why?
| | Heart Injuries | 1 | 2025 | 41 | 0.880 |
Why?
| | Prospective Studies | 25 | 2026 | 8123 | 0.870 |
Why?
| | Humans | 111 | 2026 | 146342 | 0.860 |
Why?
| | Heart Arrest | 5 | 2022 | 411 | 0.850 |
Why?
| | Wounds, Penetrating | 1 | 2025 | 71 | 0.840 |
Why?
| | Fasciotomy | 1 | 2024 | 24 | 0.820 |
Why?
| | Antivenins | 1 | 2024 | 29 | 0.820 |
Why?
| | Hospitals, Military | 3 | 2020 | 29 | 0.820 |
Why?
| | Snake Bites | 1 | 2024 | 24 | 0.820 |
Why?
| | Afghanistan | 17 | 2024 | 96 | 0.800 |
Why?
| | Apnea | 3 | 2020 | 26 | 0.780 |
Why?
| | Retrospective Studies | 34 | 2024 | 17438 | 0.770 |
Why?
| | Anesthetics, Dissociative | 1 | 2023 | 49 | 0.770 |
Why?
| | Simulation Training | 3 | 2021 | 136 | 0.770 |
Why?
| | Education, Medical, Graduate | 3 | 2025 | 568 | 0.760 |
Why?
| | Operating Rooms | 1 | 2025 | 145 | 0.750 |
Why?
| | Physicians | 5 | 2024 | 955 | 0.740 |
Why?
| | Balloon Occlusion | 2 | 2025 | 39 | 0.730 |
Why?
| | Disease Models, Animal | 14 | 2026 | 4580 | 0.700 |
Why?
| | Internship and Residency | 3 | 2025 | 1281 | 0.680 |
Why?
| | Sulfhydryl Compounds | 2 | 2020 | 189 | 0.670 |
Why?
| | Critical Illness | 5 | 2019 | 908 | 0.660 |
Why?
| | United States | 34 | 2024 | 16136 | 0.640 |
Why?
| | Aorta, Abdominal | 2 | 2018 | 51 | 0.640 |
Why?
| | Adult | 47 | 2024 | 41087 | 0.630 |
Why?
| | Male | 59 | 2025 | 73396 | 0.630 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2024 | 370 | 0.610 |
Why?
| | Emergency Service, Hospital | 14 | 2024 | 2363 | 0.590 |
Why?
| | Cobamides | 4 | 2020 | 25 | 0.580 |
Why?
| | Drug Dosage Calculations | 1 | 2019 | 27 | 0.570 |
Why?
| | Texas | 6 | 2024 | 280 | 0.570 |
Why?
| | Injury Severity Score | 10 | 2024 | 572 | 0.560 |
Why?
| | Amputation, Traumatic | 1 | 2018 | 21 | 0.540 |
Why?
| | Medication Errors | 1 | 2019 | 86 | 0.540 |
Why?
| | Hypotension | 6 | 2023 | 125 | 0.540 |
Why?
| | Burns | 1 | 2023 | 365 | 0.540 |
Why?
| | Analgesics | 6 | 2020 | 230 | 0.530 |
Why?
| | Endovascular Procedures | 2 | 2025 | 390 | 0.520 |
Why?
| | Female | 53 | 2025 | 79499 | 0.520 |
Why?
| | Hemostatic Techniques | 1 | 2018 | 50 | 0.520 |
Why?
| | Biomedical Research | 1 | 2024 | 729 | 0.500 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 2 | 2019 | 266 | 0.500 |
Why?
| | Guideline Adherence | 4 | 2024 | 594 | 0.490 |
Why?
| | Calcium Gluconate | 1 | 2016 | 4 | 0.490 |
Why?
| | Quaternary Ammonium Compounds | 1 | 2016 | 50 | 0.480 |
Why?
| | Emergency Medical Technicians | 1 | 2016 | 40 | 0.480 |
Why?
| | Hypocalcemia | 1 | 2016 | 40 | 0.470 |
Why?
| | Altitude | 1 | 2020 | 469 | 0.470 |
Why?
| | Registries | 20 | 2024 | 2400 | 0.460 |
Why?
| | Heart Diseases | 1 | 2019 | 343 | 0.460 |
Why?
| | Iraq | 10 | 2020 | 66 | 0.450 |
Why?
| | Polyradiculopathy | 1 | 2015 | 3 | 0.450 |
Why?
| | Patient Simulation | 2 | 2018 | 42 | 0.450 |
Why?
| | Spinal Cord Compression | 1 | 2015 | 24 | 0.440 |
Why?
| | Animals | 24 | 2026 | 38107 | 0.440 |
Why?
| | Telemedicine | 2 | 2015 | 966 | 0.440 |
Why?
| | Poison Control Centers | 5 | 2024 | 85 | 0.430 |
Why?
| | Emergency Treatment | 3 | 2023 | 122 | 0.420 |
Why?
| | Hydrogen Sulfide | 3 | 2020 | 47 | 0.410 |
Why?
| | Hypothermia | 3 | 2024 | 53 | 0.410 |
Why?
| | Blood Transfusion | 4 | 2025 | 394 | 0.410 |
Why?
| | Craniocerebral Trauma | 3 | 2022 | 173 | 0.410 |
Why?
| | Time Factors | 5 | 2020 | 7109 | 0.400 |
Why?
| | Cardiopulmonary Resuscitation | 4 | 2022 | 334 | 0.400 |
Why?
| | Young Adult | 15 | 2024 | 14330 | 0.390 |
Why?
| | Hematemesis | 1 | 2012 | 3 | 0.380 |
Why?
| | Stomach Diseases | 1 | 2012 | 18 | 0.370 |
Why?
| | Sus scrofa | 4 | 2024 | 64 | 0.370 |
Why?
| | beta-Alanine | 1 | 2012 | 25 | 0.370 |
Why?
| | Citalopram | 1 | 2012 | 33 | 0.360 |
Why?
| | Antithrombins | 1 | 2012 | 71 | 0.360 |
Why?
| | Medical Records | 3 | 2023 | 193 | 0.350 |
Why?
| | Benzimidazoles | 1 | 2012 | 191 | 0.340 |
Why?
| | Education, Medical | 1 | 2014 | 274 | 0.340 |
Why?
| | Hyperoxia | 2 | 2025 | 126 | 0.330 |
Why?
| | Self-Injurious Behavior | 1 | 2012 | 129 | 0.320 |
Why?
| | Tranexamic Acid | 2 | 2023 | 63 | 0.320 |
Why?
| | Tachycardia, Ventricular | 1 | 2012 | 179 | 0.320 |
Why?
| | Referral and Consultation | 1 | 2016 | 881 | 0.310 |
Why?
| | Lung | 2 | 2020 | 4122 | 0.310 |
Why?
| | Aerospace Medicine | 3 | 2018 | 32 | 0.300 |
Why?
| | Blast Injuries | 2 | 2021 | 62 | 0.300 |
Why?
| | Mass Casualty Incidents | 2 | 2022 | 52 | 0.290 |
Why?
| | Drug Overdose | 3 | 2012 | 377 | 0.290 |
Why?
| | Laryngoscopy | 3 | 2025 | 122 | 0.290 |
Why?
| | Analgesics, Opioid | 4 | 2020 | 1221 | 0.290 |
Why?
| | Pain | 3 | 2018 | 790 | 0.270 |
Why?
| | Aircraft | 2 | 2025 | 21 | 0.270 |
Why?
| | Point-of-Care Systems | 2 | 2021 | 185 | 0.260 |
Why?
| | Clinical Competence | 5 | 2025 | 1272 | 0.250 |
Why?
| | Algorithms | 2 | 2026 | 1849 | 0.240 |
Why?
| | Airway Obstruction | 2 | 2019 | 152 | 0.240 |
Why?
| | Shock, Traumatic | 2 | 2023 | 14 | 0.230 |
Why?
| | Hematinics | 1 | 2026 | 22 | 0.230 |
Why?
| | Pneumothorax | 1 | 2026 | 54 | 0.230 |
Why?
| | Gases | 2 | 2023 | 45 | 0.230 |
Why?
| | Antifibrinolytic Agents | 2 | 2023 | 68 | 0.220 |
Why?
| | Erythropoietin | 1 | 2026 | 100 | 0.210 |
Why?
| | Wound Infection | 1 | 2025 | 60 | 0.210 |
Why?
| | Acute Kidney Injury | 1 | 2012 | 866 | 0.210 |
Why?
| | Crotalinae | 1 | 2024 | 1 | 0.210 |
Why?
| | Triage | 3 | 2022 | 243 | 0.210 |
Why?
| | Child, Preschool | 7 | 2024 | 11913 | 0.210 |
Why?
| | Germany | 1 | 2024 | 139 | 0.200 |
Why?
| | Antibiotic Prophylaxis | 1 | 2025 | 140 | 0.200 |
Why?
| | Crotalid Venoms | 1 | 2024 | 30 | 0.200 |
Why?
| | Random Allocation | 3 | 2020 | 366 | 0.200 |
Why?
| | Blood Component Removal | 1 | 2024 | 26 | 0.200 |
Why?
| | Seasons | 2 | 2024 | 540 | 0.200 |
Why?
| | Isotonic Solutions | 1 | 2023 | 43 | 0.190 |
Why?
| | Middle Aged | 10 | 2024 | 36619 | 0.190 |
Why?
| | Treatment Outcome | 10 | 2023 | 11821 | 0.190 |
Why?
| | Chi-Square Distribution | 3 | 2019 | 517 | 0.180 |
Why?
| | Ventilators, Mechanical | 1 | 2023 | 70 | 0.180 |
Why?
| | Adolescent | 9 | 2024 | 22557 | 0.180 |
Why?
| | Fibrinolysis | 1 | 2023 | 162 | 0.180 |
Why?
| | Wounds, Nonpenetrating | 2 | 2025 | 305 | 0.170 |
Why?
| | Acidosis | 1 | 2023 | 105 | 0.170 |
Why?
| | Infusions, Intravenous | 2 | 2020 | 432 | 0.170 |
Why?
| | Fluid Therapy | 1 | 2023 | 154 | 0.170 |
Why?
| | Renal Insufficiency | 1 | 2024 | 173 | 0.170 |
Why?
| | Methanol | 2 | 2023 | 43 | 0.170 |
Why?
| | Thiosulfates | 1 | 2021 | 19 | 0.170 |
Why?
| | Ultrasonography | 2 | 2026 | 788 | 0.160 |
Why?
| | Amitriptyline | 2 | 2011 | 25 | 0.160 |
Why?
| | Antidepressive Agents, Tricyclic | 2 | 2011 | 30 | 0.160 |
Why?
| | Shock | 1 | 2022 | 101 | 0.160 |
Why?
| | Extremities | 1 | 2022 | 142 | 0.160 |
Why?
| | Research | 3 | 2022 | 421 | 0.160 |
Why?
| | Analgesia | 2 | 2018 | 106 | 0.160 |
Why?
| | Occupations | 1 | 2020 | 50 | 0.160 |
Why?
| | Injections, Intramuscular | 4 | 2023 | 140 | 0.160 |
Why?
| | Cyanides | 1 | 2021 | 58 | 0.160 |
Why?
| | Physician Assistants | 1 | 2022 | 102 | 0.160 |
Why?
| | Etomidate | 1 | 2020 | 23 | 0.160 |
Why?
| | Prescription Drug Monitoring Programs | 1 | 2020 | 18 | 0.160 |
Why?
| | Medical Errors | 2 | 2020 | 124 | 0.150 |
Why?
| | Curriculum | 2 | 2025 | 1079 | 0.150 |
Why?
| | Thiadiazoles | 1 | 2020 | 25 | 0.150 |
Why?
| | Fellowships and Scholarships | 1 | 2024 | 355 | 0.150 |
Why?
| | Surveys and Questionnaires | 3 | 2025 | 6073 | 0.150 |
Why?
| | Hypovolemia | 1 | 2019 | 6 | 0.150 |
Why?
| | Blood Pressure | 2 | 2023 | 1765 | 0.150 |
Why?
| | Heart Rate | 1 | 2023 | 846 | 0.150 |
Why?
| | Heart Massage | 1 | 2019 | 11 | 0.140 |
Why?
| | Opioid-Related Disorders | 2 | 2018 | 634 | 0.140 |
Why?
| | Pain Management | 2 | 2020 | 421 | 0.140 |
Why?
| | Clinical Protocols | 2 | 2018 | 282 | 0.140 |
Why?
| | Aorta, Thoracic | 2 | 2020 | 284 | 0.140 |
Why?
| | Armed Conflicts | 1 | 2019 | 16 | 0.140 |
Why?
| | Survival Analysis | 5 | 2019 | 1378 | 0.140 |
Why?
| | Eating | 2 | 2023 | 386 | 0.140 |
Why?
| | Spinal Injuries | 1 | 2019 | 62 | 0.140 |
Why?
| | Aged | 7 | 2024 | 26432 | 0.140 |
Why?
| | Documentation | 1 | 2020 | 202 | 0.140 |
Why?
| | Succinylcholine | 1 | 2018 | 7 | 0.140 |
Why?
| | Child | 8 | 2024 | 22693 | 0.140 |
Why?
| | Databases, Factual | 1 | 2024 | 1493 | 0.140 |
Why?
| | Norepinephrine | 1 | 2019 | 201 | 0.130 |
Why?
| | Torso | 1 | 2018 | 36 | 0.130 |
Why?
| | Ethanol | 1 | 2023 | 630 | 0.130 |
Why?
| | Military Facilities | 1 | 2017 | 4 | 0.130 |
Why?
| | Military Nursing | 1 | 2018 | 19 | 0.130 |
Why?
| | Administration, Intravenous | 4 | 2019 | 172 | 0.130 |
Why?
| | Tablets | 1 | 2017 | 41 | 0.130 |
Why?
| | Hydrocodone | 1 | 2017 | 20 | 0.130 |
Why?
| | Exanthema | 1 | 2018 | 86 | 0.130 |
Why?
| | Cardiovascular Agents | 1 | 2019 | 165 | 0.130 |
Why?
| | Cervical Vertebrae | 1 | 2019 | 170 | 0.130 |
Why?
| | Tidal Volume | 1 | 2018 | 108 | 0.130 |
Why?
| | Hemostatics | 1 | 2018 | 66 | 0.130 |
Why?
| | Tracheostomy | 1 | 2019 | 136 | 0.120 |
Why?
| | Ammonium Compounds | 1 | 2016 | 2 | 0.120 |
Why?
| | Dextromethorphan | 1 | 2016 | 24 | 0.120 |
Why?
| | Hydrofluoric Acid | 1 | 2016 | 7 | 0.120 |
Why?
| | Pelvis | 1 | 2018 | 129 | 0.120 |
Why?
| | Headache | 1 | 2017 | 150 | 0.120 |
Why?
| | Epidemics | 1 | 2018 | 97 | 0.120 |
Why?
| | Abdominal Injuries | 1 | 2018 | 122 | 0.120 |
Why?
| | Tertiary Care Centers | 1 | 2017 | 196 | 0.120 |
Why?
| | Abdomen | 1 | 2017 | 142 | 0.120 |
Why?
| | Morphine | 4 | 2019 | 171 | 0.120 |
Why?
| | Fluorides | 1 | 2016 | 50 | 0.120 |
Why?
| | Musculoskeletal Diseases | 1 | 2017 | 95 | 0.120 |
Why?
| | Ventricular Fibrillation | 1 | 2016 | 63 | 0.120 |
Why?
| | Inpatients | 1 | 2020 | 540 | 0.120 |
Why?
| | Wounds, Gunshot | 1 | 2020 | 262 | 0.120 |
Why?
| | Personal Protective Equipment | 1 | 2016 | 59 | 0.110 |
Why?
| | Cohort Studies | 2 | 2024 | 6077 | 0.110 |
Why?
| | Milk | 1 | 2016 | 117 | 0.110 |
Why?
| | Pandemics | 1 | 2024 | 1707 | 0.110 |
Why?
| | Patient Outcome Assessment | 1 | 2016 | 129 | 0.110 |
Why?
| | Communicable Disease Control | 1 | 2016 | 88 | 0.110 |
Why?
| | Urinary Retention | 1 | 2015 | 23 | 0.110 |
Why?
| | Gastrointestinal Diseases | 1 | 2017 | 220 | 0.110 |
Why?
| | Chronic Pain | 1 | 2020 | 304 | 0.110 |
Why?
| | Hemorrhagic Fever, Ebola | 1 | 2016 | 82 | 0.110 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 861 | 0.110 |
Why?
| | Survival Rate | 2 | 2018 | 2092 | 0.110 |
Why?
| | Patient Safety | 1 | 2019 | 352 | 0.110 |
Why?
| | Analysis of Variance | 1 | 2017 | 1298 | 0.110 |
Why?
| | Thoracic Vertebrae | 1 | 2015 | 90 | 0.110 |
Why?
| | United States Department of Defense | 3 | 2019 | 26 | 0.110 |
Why?
| | Proportional Hazards Models | 1 | 2018 | 1331 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1942 | 0.100 |
Why?
| | Oxygen | 1 | 2019 | 997 | 0.100 |
Why?
| | Nurses | 1 | 2016 | 171 | 0.100 |
Why?
| | Low Back Pain | 1 | 2015 | 109 | 0.100 |
Why?
| | Communication | 1 | 2020 | 980 | 0.100 |
Why?
| | Pilot Projects | 3 | 2026 | 1888 | 0.100 |
Why?
| | Lumbar Vertebrae | 1 | 2015 | 260 | 0.100 |
Why?
| | Health Personnel | 2 | 2018 | 754 | 0.090 |
Why?
| | Dabigatran | 1 | 2012 | 30 | 0.090 |
Why?
| | Video Recording | 2 | 2025 | 219 | 0.090 |
Why?
| | Fatal Outcome | 1 | 2012 | 302 | 0.090 |
Why?
| | Fentanyl | 3 | 2018 | 126 | 0.090 |
Why?
| | Lower Extremity | 1 | 2015 | 453 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2015 | 1503 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1408 | 0.080 |
Why?
| | Infant, Newborn | 2 | 2021 | 6460 | 0.080 |
Why?
| | Diphenhydramine | 1 | 2010 | 36 | 0.080 |
Why?
| | Calcium | 1 | 2016 | 1181 | 0.080 |
Why?
| | Hypoxia | 1 | 2018 | 1211 | 0.080 |
Why?
| | Infant | 3 | 2021 | 10114 | 0.070 |
Why?
| | Electrocardiography | 1 | 2012 | 667 | 0.070 |
Why?
| | Incidence | 4 | 2019 | 2936 | 0.070 |
Why?
| | Quality Improvement | 1 | 2018 | 1354 | 0.070 |
Why?
| | Logistic Models | 2 | 2024 | 2126 | 0.060 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2006 | 195 | 0.060 |
Why?
| | Pain Measurement | 2 | 2018 | 573 | 0.060 |
Why?
| | Genetic Vectors | 1 | 2006 | 327 | 0.050 |
Why?
| | Feedback | 1 | 2025 | 183 | 0.050 |
Why?
| | Equipment Reuse | 1 | 2024 | 18 | 0.050 |
Why?
| | Anemia | 1 | 2026 | 190 | 0.050 |
Why?
| | Genetic Therapy | 1 | 2006 | 303 | 0.050 |
Why?
| | Viruses | 1 | 2006 | 165 | 0.050 |
Why?
| | Ambulances | 1 | 2023 | 52 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3926 | 0.050 |
Why?
| | Practice Guidelines as Topic | 1 | 2010 | 1591 | 0.040 |
Why?
| | South Africa | 1 | 2023 | 262 | 0.040 |
Why?
| | Hawaii | 1 | 2022 | 38 | 0.040 |
Why?
| | Vital Signs | 1 | 2022 | 39 | 0.040 |
Why?
| | Aorta | 1 | 2025 | 440 | 0.040 |
Why?
| | Japan | 1 | 2022 | 149 | 0.040 |
Why?
| | Blood Coagulation Disorders | 1 | 2023 | 190 | 0.040 |
Why?
| | Prognosis | 2 | 2021 | 4351 | 0.040 |
Why?
| | Pressure | 1 | 2022 | 221 | 0.040 |
Why?
| | Cadaver | 1 | 2022 | 304 | 0.040 |
Why?
| | Hospitalization | 2 | 2024 | 2475 | 0.040 |
Why?
| | Appointments and Schedules | 1 | 2021 | 97 | 0.040 |
Why?
| | Infusions, Intraosseous | 1 | 2020 | 20 | 0.040 |
Why?
| | Arterial Pressure | 1 | 2021 | 130 | 0.040 |
Why?
| | Inhalation Exposure | 1 | 2020 | 103 | 0.040 |
Why?
| | Abbreviated Injury Scale | 1 | 2019 | 28 | 0.040 |
Why?
| | Primary Health Care | 2 | 2021 | 1776 | 0.040 |
Why?
| | Intersectoral Collaboration | 1 | 2020 | 64 | 0.040 |
Why?
| | Epithelial Cells | 1 | 2006 | 1119 | 0.040 |
Why?
| | Prescription Drug Misuse | 1 | 2020 | 58 | 0.040 |
Why?
| | Pulse | 1 | 2019 | 30 | 0.040 |
Why?
| | Syria | 1 | 2019 | 6 | 0.040 |
Why?
| | Models, Animal | 1 | 2021 | 387 | 0.040 |
Why?
| | Monitoring, Physiologic | 1 | 2021 | 279 | 0.040 |
Why?
| | Echocardiography | 1 | 2022 | 645 | 0.040 |
Why?
| | Trauma Severity Indices | 1 | 2018 | 115 | 0.030 |
Why?
| | Administration, Oral | 1 | 2021 | 872 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2018 | 197 | 0.030 |
Why?
| | Dextropropoxyphene | 1 | 2017 | 4 | 0.030 |
Why?
| | Sex Distribution | 1 | 2019 | 382 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2020 | 615 | 0.030 |
Why?
| | Drug Prescriptions | 1 | 2020 | 314 | 0.030 |
Why?
| | Tramadol | 1 | 2017 | 17 | 0.030 |
Why?
| | Glasgow Coma Scale | 1 | 2018 | 211 | 0.030 |
Why?
| | Catheterization, Peripheral | 1 | 2019 | 116 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2022 | 762 | 0.030 |
Why?
| | Developing Countries | 1 | 2019 | 312 | 0.030 |
Why?
| | Human Experimentation | 1 | 2016 | 12 | 0.030 |
Why?
| | Telephone | 1 | 2017 | 175 | 0.030 |
Why?
| | Sodium Chloride | 1 | 2017 | 138 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2019 | 721 | 0.030 |
Why?
| | Sulfides | 1 | 2017 | 92 | 0.030 |
Why?
| | Shock, Septic | 1 | 2019 | 230 | 0.030 |
Why?
| | Hydromorphone | 1 | 2016 | 10 | 0.030 |
Why?
| | Research Subjects | 1 | 2016 | 42 | 0.030 |
Why?
| | Ethics Committees, Research | 1 | 2016 | 41 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2018 | 970 | 0.030 |
Why?
| | Decision Support Systems, Clinical | 1 | 2020 | 279 | 0.030 |
Why?
| | Prevalence | 1 | 2023 | 2861 | 0.030 |
Why?
| | Quality Assurance, Health Care | 1 | 2018 | 349 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 2020 | 777 | 0.030 |
Why?
| | Educational Measurement | 1 | 2018 | 331 | 0.030 |
Why?
| | Travel | 1 | 2016 | 134 | 0.030 |
Why?
| | Patient Education as Topic | 1 | 2020 | 770 | 0.030 |
Why?
| | Infection Control | 1 | 2016 | 174 | 0.030 |
Why?
| | Program Evaluation | 1 | 2018 | 952 | 0.030 |
Why?
| | Disease Outbreaks | 1 | 2016 | 422 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2021 | 1107 | 0.020 |
Why?
| | Qualitative Research | 1 | 2020 | 1734 | 0.020 |
Why?
| | Coma | 1 | 2010 | 39 | 0.020 |
Why?
| | Sleep Stages | 1 | 2010 | 76 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2919 | 0.020 |
Why?
| | Substance-Related Disorders | 1 | 2017 | 1100 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 4340 | 0.020 |
Why?
| | Arrhythmias, Cardiac | 1 | 2010 | 358 | 0.020 |
Why?
| | Genes, Viral | 1 | 2006 | 88 | 0.010 |
Why?
| | Lentivirus | 1 | 2006 | 61 | 0.010 |
Why?
| | Luciferases | 1 | 2006 | 153 | 0.010 |
Why?
| | Seizures | 1 | 2010 | 489 | 0.010 |
Why?
| | Genetic Engineering | 1 | 2006 | 89 | 0.010 |
Why?
| | Dependovirus | 1 | 2006 | 78 | 0.010 |
Why?
| | Adenoviridae | 1 | 2006 | 197 | 0.010 |
Why?
| | Plasmids | 1 | 2006 | 373 | 0.010 |
Why?
| | HeLa Cells | 1 | 2006 | 636 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2006 | 1271 | 0.010 |
Why?
| | Mice | 1 | 2020 | 18297 | 0.010 |
Why?
| | Hypertension | 1 | 2010 | 1272 | 0.010 |
Why?
| | Gene Expression | 1 | 2006 | 1463 | 0.010 |
Why?
| | Cell Line | 1 | 2006 | 2814 | 0.010 |
Why?
|
|
Maddry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|